Mon, November 13, 2023

David Westenberg Maintained (ADPT) at Buy with Decreased Target to $6 on, Nov 13th, 2023

David Westenberg of Piper Sandler, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Buy with Decreased Target from $13 to $6 on, Nov 13th, 2023.

David has made no other calls on ADPT in the last 4 months.



There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $10 on, Tuesday, October 24th, 2023


This is the rating of the analyst that currently disagrees with David


  • Rachel Vatnsdal of "JP Morgan" Maintained at Buy with Decreased Target to $11 on, Friday, November 10th, 2023